Skip to content
DAT Supply Log in
Botanicals · Gummies

Cordyceps Extract

Cordyceps militaris is a cultivated medicinal mushroom used in gummy and sachet formats for energy and vitality positioning. It is one of the most familiar functional mushroom ingredients across EU and US supplement markets. As a botanical on the EU on-hold list, it carries no authorised health claims under Reg. 432/2012, so claim coverage relies on co-formulated nutrients such as Vitamin B6 or Magnesium.

  • energy-and-vitality
  • sports-recovery
  • healthy-ageing
Build a formula with this ingredient
Cordyceps Extract

At a glance

Definition
Cordyceps militaris is a cultivated medicinal mushroom used in gummy and sachet formats for energy and vitality positioning. It is one of the most familiar functional mushroom ingredients across EU and US supplement markets. As a botanical on the EU on-hold list, it carries no authorised health claims under Reg. 432/2012, so claim coverage relies on co-formulated nutrients such as Vitamin B6 or Magnesium.
Authorised wording (summary)
2 authorised statements — see "US structure-function statements" below.
Common positionings
  • natural energy support
  • sports endurance positioning
  • vitality and stamina
  • healthy ageing support
  • adaptogenic wellness
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Cordyceps militaris is a cultivated medicinal mushroom species used in dietary supplements for its association with energy, endurance, and vitality. Unlike its wild-harvested relative Cordyceps sinensis, C. militaris is commercially cultivated on grain substrates, making it a scalable and consistent raw material for private-label manufacturing. The ingredient is standardised to polysaccharide content, typically beta-glucans, which serve as the primary marker compound for batch consistency.

Brands select cordyceps for gummy formats because it supports positioning around natural energy, sports recovery, and healthy ageing. The ingredient has strong consumer recognition in the functional mushroom category, particularly among active lifestyle and wellness audiences. For EU markets, all claim wording must be anchored to co-formulated nutrients with authorised health claims, as cordyceps itself carries no EFSA-authorised claims under Regulation 432/2012.

Origin and history

Cordyceps has been used in traditional Chinese medicine for centuries, originally harvested from wild caterpillar fungus (Cordyceps sinensis) found in high-altitude regions of the Himalayas and Tibetan Plateau. Modern commercial production shifted to Cordyceps militaris, which can be reliably cultivated on sterilised grain substrates in controlled environments. This cultivation method ensures consistent polysaccharide profiles and eliminates the ecological concerns associated with wild harvesting.

Industrial production involves inoculating grain substrates with Cordyceps militaris mycelium, followed by controlled incubation and fruiting. The harvested fruiting bodies are dried, milled, and standardised to a specified polysaccharide content. For gummy manufacturing, the extract is typically processed as a fine powder that disperses evenly in the gummy matrix without affecting texture or clarity.

Scientific overview

Cordyceps militaris contains bioactive polysaccharides, including beta-glucans, along with cordycepin, adenosine, and ergosterol. Beta-glucans are the primary marker compounds used for standardisation in commercial extracts. The polysaccharide fraction is associated with modulation of cellular energy metabolism, which underpins the ingredient's traditional positioning for stamina and vitality. Cordycepin, a nucleoside analogue, has been the subject of research interest for its role in cellular signalling pathways.

Bioavailability of cordyceps polysaccharides is influenced by molecular weight and extraction method. Hot-water extraction yields high-molecular-weight polysaccharides, while dual extraction (water plus alcohol) captures a broader range of compounds. For gummy applications, standardised extracts with consistent polysaccharide profiles are preferred to ensure batch-to-batch reproducibility. The ingredient is heat-stable and soluble in gummy formulations, requiring no special processing conditions.

Manufacturing watchpoints include the variability in polysaccharide content between different suppliers and extraction methods. Brands should specify a minimum polysaccharide standardisation (typically 30% beta-glucans) in their raw material specifications. Cordyceps is cost-effective at mid-tier pricing compared to other functional mushrooms, making it suitable for mass-market gummy products. DAT reviews raw material specifications per project.

Why brands use Cordyceps Extract

Cordyceps occupies a strong position in the functional mushroom category, which has grown significantly across EU and US supplement markets. It is one of the most familiar and commercially understood mushroom actives for gummy formats, competing with reishi, lion's mane, and chaga. Brand founders use cordyceps to target active lifestyle consumers, sports nutrition audiences, and healthy ageing demographics. The ingredient's earthy flavour is mild and easily masked by fruit flavours, making it suitable for gummy products without requiring heavy flavouring.

From a formulation perspective, cordyceps extract integrates well into standard gummy manufacturing processes. It is heat-stable, soluble, and does not require encapsulation or specialised handling. The typical dosage range of 500–3000 mg per serving is achievable in a standard gummy piece, though higher doses may require larger format gummies or multiple-piece servings. Cost per serving is moderate, allowing for competitive retail pricing while maintaining margin. DAT confirms final dosage and format feasibility per project.

For pack copy, brands must observe strict claim discipline in EU markets. Cordyceps carries no authorised health claims under Regulation 432/2012, so all consumer-facing claims must be anchored to co-formulated nutrients. For example, a cordyceps gummy co-formulated with Vitamin B6 can use the authorised claim "Vitamin B6 contributes to normal energy-yielding metabolism." Co-formulation with Magnesium supports "Magnesium contributes to normal muscle function." DAT reviews all claim wording per project to ensure compliance with EU and UK regulations.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Medium

Forms available

  • Polysaccharide-standardised extract (typically 30% beta-glucans), whole fruiting body powder, mycelial biomass powder

Dosage reference

Typical brand positioning range is 500–3000 mg per serving. No reference-intake target reviewed per market established. DAT confirms target dose per project based on extract standardisation and format.

Taste & sensory

Mild earthy flavour that masks well in fruit-flavoured gummy bases. No significant bitterness.

Manufacturing notes

Mushroom extracts require polysaccharide-standardised raw material for batch consistency. Probiotic co-formulations require separate manufacturing considerations due to heat sensitivity. DAT reviews per project.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

US structure-function statements

  • Supports energy and vitality as part of a healthy lifestyle.Structure-function (DSHEA)
  • Helps support endurance during physical activity.Structure-function (DSHEA)

Structure-function statements must appear with the FDA disclaimer in the same field of vision on the label. % Daily Value (DV) based on FDA 21 CFR 101.9.

Wording to avoid on pack copy

  • No disease claims — this product is not intended to diagnose, treat, cure, or prevent any disease.
  • Structure-function claims must be accompanied by the FDA disclaimer: 'These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.'
  • No certification promises on pack until confirmed per project and batch documentation.
  • No guaranteed shelf-life on pack until confirmed with stability data.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Structure-function claims are permitted under DSHEA (21 USC §343(r)(6)). No Daily Value (DV) has been established for cordyceps under FDA 21 CFR 101.9.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Zhou X, Gong Z, Su Y, Lin J, Tang K·Journal of Ethnopharmacology·2009

  2. Hirsch KR, Smith-Ryan AE, Roelofs EJ, Trexler ET, Mock MG·Nutrients·2017

  3. Chen S, Li Z, Krochmal R, Abrazado M, Kim W, Cooper CB·Journal of Alternative and Complementary Medicine·2010

  4. EFSA Panel on Dietetic Products, Nutrition and Allergies·EFSA Journal·2019

  5. Liu Y, Wang J, Wang W, Zhang H, Zhang X, Han C·International Journal of Biological Macromolecules·2021

  6. European Parliament and Council·Official Journal of the European Union·2006

Catalogue match

Product concepts featuring Cordyceps Extract

Private-label product concepts where Cordyceps Extract appears in the formula. Each opens to a product brief and quote route.

Synergies & conflicts

Pairs well with

Cordyceps pairs well with other functional mushrooms (reishi, lion's mane) and adaptogens (ashwagandha, rhodiola). Co-formulation with Vitamin B6 or Magnesium can support nervous-system claims.

Care when combining with

No known conflicts with common gummy nutrients. Avoid co-formulation with high-dose caffeine in products targeting sleep positioning.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Cordyceps Extract on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Cordyceps Extract.

Project handoff

Develop a formula featuring Cordyceps Extract

A ready white-label formula exists — open a product brief, or talk to our team to align the launch plan.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.